BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2224129)

  • 21. bcr rearrangement and C-abl gene expression in Ph1-positive hybrid acute leukemia with simultaneous proliferation of lymphoid and myeloid blasts.
    Okabe M; Oita M; Kunieda Y; Matsuura J; Sakurada K; Matsushima S; Kakinuma M; Miyazaki T
    Blut; 1989 May; 58(5):241-6. PubMed ID: 2655744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Inoue T; Tojo A; Futaki M; Miyake K; Yamada T; Tanabe Y; Ohki I; Dan K; Ozawa K
    Blood; 1991 Dec; 78(12):3125-7. PubMed ID: 1742479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Entire ABL gene is joined with 5'-BCR in some patients with Philadelphia-positive leukemia.
    Morris CM; Heisterkamp N; Groffen J; Fitzgerald PH
    Blood; 1991 Aug; 78(4):1078-84. PubMed ID: 1868241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein.
    Wada H; Mizutani S; Nishimura J; Usuki Y; Kohsaki M; Komai M; Kaneko H; Sakamoto S; Delia D; Kanamaru A
    Cancer Res; 1995 Jul; 55(14):3192-6. PubMed ID: 7606740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translocation of BCR to chromosome 9 in a Philadelphia-negative chronic myeloid leukemia.
    Brunel V; Sainty D; Costello R; Mozziconacci MJ; Simonetti J; Arnoulet C; Coignet L; Bouabdallah R; Gastaut JA; Gabert J
    Cancer Genet Cytogenet; 1995 Nov; 85(1):82-4. PubMed ID: 8536245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of breakpoints, and relationship to BCR-ABL RNA expression, in Philadelphia-chromosome-positive chronic myeloid leukaemia patients with a breakpoint around exon 14 (b3) of the BCR gene.
    Mills KI; Sproul AM; Leibowitz D; Burnett AK
    Leukemia; 1991 Nov; 5(11):937-41. PubMed ID: 1961034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.
    Liu LG; Tanaka H; Ito K; Kyo T; Ito T; Kimura A
    Am J Hematol; 2003 Dec; 74(4):268-72. PubMed ID: 14635208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between the type of bcr-abl hybrid messenger RNA and thrombopoiesis in Philadelphia-positive chronic myelogenous leukemia.
    Inokuchi K; Nomura T
    Leuk Lymphoma; 1993 May; 10(1-2):9-15. PubMed ID: 8374529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
    Grossman A; Silver RT; Arlin Z; Coleman M; Camposano E; Gascon P; Benn PA
    Am J Hum Genet; 1989 Nov; 45(5):729-38. PubMed ID: 2683759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia.
    Abeliovich D; Yehuda O; Krichevsky S; Nagler A; Ben-Neriah S; Werner M; Ludkovsky O; Ben-Yehuda D
    Cancer Genet Cytogenet; 1995 Jun; 81(2):115-7. PubMed ID: 7621406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.
    Iwata S; Mizutani S; Nakazawa S; Yata J
    Leukemia; 1994 Oct; 8(10):1696-702. PubMed ID: 7934165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic characterization of the tumor-specific bcr-abl junction in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    van Denderen J; van der Plas D; Meeuwsen T; Zegers N; Boersma W; Grosveld G; van Ewijk W
    Blood; 1990 Jul; 76(1):136-41. PubMed ID: 2194587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.
    Muller AJ; Young JC; Pendergast AM; Pondel M; Landau NR; Littman DR; Witte ON
    Mol Cell Biol; 1991 Apr; 11(4):1785-92. PubMed ID: 2005881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation.
    Chen SJ; Chen Z; Font MP; d'Auriol L; Larsen CJ; Berger R
    Nucleic Acids Res; 1989 Oct; 17(19):7631-42. PubMed ID: 2678002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duplication of small segments within the major breakpoint cluster region in chronic myelogenous leukemia.
    Litz CE; McClure JS; Copenhaver CM; Brunning RD
    Blood; 1993 Mar; 81(6):1567-72. PubMed ID: 8453102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular biology of chronic myeloid leukemia.
    Maru Y
    Int J Hematol; 2001 Apr; 73(3):308-22. PubMed ID: 11345196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive characterization of a novel intronic pseudo-exon inserted within an e14/a2 BCR-ABL rearrangement in a patient with chronic myeloid leukemia.
    Sorel N; Mayeur-Rousse C; Deverrière S; Roy L; Brottier-Mancini E; Guilhot F; Turhan AG; Chomel JC
    J Mol Diagn; 2010 Jul; 12(4):520-4. PubMed ID: 20508029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins.
    Demiroglu A; Steer EJ; Heath C; Taylor K; Bentley M; Allen SL; Koduru P; Brody JP; Hawson G; Rodwell R; Doody ML; Carnicero F; Reiter A; Goldman JM; Melo JV; Cross NC
    Blood; 2001 Dec; 98(13):3778-83. PubMed ID: 11739186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.